Gilead Sciences Inc (GILD)

Industry Drug Manufacturers - General


This stock can be held in an Investment ISA and an Investment Account
Sell

$92.67

Buy

$93.00

arrow-down$-1.72 (-1.82%)

Prices updated at 13 Nov 2024, 23:30 EST
| Prices minimum 15 mins delay
|
Prices in USD

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Most recent dividend payment

0.770
Cash Dividend
13 Dec 2024
06 Nov 2024
13 Dec 2024
30 Dec 2024

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20243.0800-
20233.00000.03
20222.92000.03
20212.84000.04
20202.72000.08
20192.52000.11
20182.28000.10
20172.08000.13
20161.84000.43
20151.2900-

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20243.450.62
20233.701.25
20223.400.47
20213.910.36
20204.671.93
20193.882.89
20183.652.19
20172.901.75
20162.5713.60
20151.275.99

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20243.0800
20233.0000
20222.9200
20212.8400
20202.7200
20192.5200
20182.2800
20172.0800
20161.8400
20151.2900

% of earnings paid to shareholders data table

YearPayout ratio (%)
2024370.73
202363.81
2022109.85
202147.87
2020272.45
2019116.04
2018182.79
201723.09
201616.71
20157.89
Latest Financial Report as of 12 Nov 2024
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.